Zimmer Biomet Holdings Inc (ZBH) Stock Price Today
Aura AI Summary
Key Stats
- $17.26BMarket Cap
- -Volume
- HealthSector
- $107.7152W High
- $79.5852W Low
- -Typical Hold Time
- $24.31BEnterprise Value
- 1.08%Div Yield
- -Trading Activity
Track Zimmer Biomet Holdings Inc (ZBH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Zimmer Biomet Holdings Inc has traded between a low of $79.58 and a high of $107.71, highlighting its annual price range. Buy and sell Zimmer Biomet Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Most Recent News
Document AI market to nearly double to $27.62B by 2030, driven by AI and automation in regulated industries.
The Document AI market is forecasted to grow from $14.66 billion in 2025 to $27.62 billion by 2030, at a CAGR of 13.5%. This growth is fueled by organizations adopting AI technologies like intelligent document processing, generative AI, and workflow ...

AI in orthopedic surgery market to hit $0.87B by 2030 with 27.2% CAGR, driven by tech advances and rising musculoskeletal disorders
The AI in orthopedic surgery market is projected to grow from $0.26 billion in 2025 to $0.87 billion by 2030, at a CAGR of 27.2%. Growth is fueled by increased orthopedic surgeries, innovations in medical imaging, adoption of minimally invasive techn...

Generative AI in drug discovery market to reach $0.86B by 2030, growing at 27% CAGR driven by faster drug development and AI advances
The generative AI market in drug discovery is expanding rapidly, expected to grow from $0.33 billion in 2026 to $0.86 billion by 2030 with a 27% CAGR. Growth is fueled by rising drug development costs, advances in AI technologies like deep learning, ...
